RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relay Therapeutics (RLAY) Valuation After Breakthrough Therapy Win And Narrower Loss Attracts Fresh Investor Interest [Yahoo! Finance]
Relay Therapeutics (RLAY) had its price target raised by Wells Fargo & Company from $13.00 to $15.00. They now have an "overweight" rating on the stock.
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones [Yahoo! Finance]
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March [Yahoo! Finance]
Form S-8 Relay Therapeutics, Inc.
Form 10-K Relay Therapeutics, Inc. For: Dec 31
Form 8-K Relay Therapeutics, Inc. For: Feb 26
Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: Casdin Capital, LLC
Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: Casdin Capital, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.